Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Skin Blood Flow Measured By LSCI Demonstrates Treatment Effect of Chronic Transfusion Protocol in Sickle Cell Disease

Nicolas V Currier, MD PhD, Gersham Dent, PhD, Paul S. Swerdlow, MD, Willem Birkhoff, MD, Jacobus Burggraaf, MD PhD, Jaspert de Vries, Bsc, Jaladhar Neelavalli, PhD, Muhammad Shahid, MD, Brijesh K Yadav, MS, William E. Hobbs, MD PhD, Ajay Verma, MD PhD

Blood (2016) 128 (22): 4871.

https://doi.org/10.1182/blood.V128.22.4871.4871

Published: 2016

Journal Articles

Pomalidomide In Sickle Cell Disease: Phase I Study Of a Novel Anti-Switching Agent

Abdullah Kutlar, MD, Paul S. Swerdlow, MD, Steffen E. Meiler, MD, Kavita Natrajan, MBBS, Leigh G Wells, MSN, RN, FNP-BC, Betsy Clair, Sheetal Shah, BA, Robert Knight, MD

Blood (2013) 122 (21): 777.

https://doi.org/10.1182/blood.V122.21.777.777

Published: 2013

Journal Articles

Hypogonadism in Men with Sickle Cell Disease (SCD): Benign Hematology Clinic, Detroit Medical Center, Detroit, MI

Abay Taddesse, MD, Indryas Woldie, MD, Panchali Khana, MD, Paul S. Swerdlow, MD, Jerry Chu, PhD, Judith Abrams, PhD, Abdul Abou-Samra, MD, PhD

Blood (2011) 118 (21): 2132.

https://doi.org/10.1182/blood.V118.21.2132.2132

Published: 2011

Journal Articles

Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice

Steffen E. Meiler, Marlene Wade, Ferdane Kutlar, Shobha D. Yerigenahally, Yongjun Xue, Laure A. Moutouh-de Parseval, Laura G. Corral, Paul S. Swerdlow, Abdullah Kutlar

Blood (2011) 118 (4): 1109–1112.

https://doi.org/10.1182/blood-2010-11-319137

Published: 2011

Includes: Supplemental data

Journal Articles

A Randomized Trial of the Safety and Benefit of Transfusion Vs. Standard Care In the Prevention of Sickle Cell-Related Complications In Adults: a Preliminary Report From the Phase II NHLBI Comprehensive Sickle Cell Centers (CSCC) Study of Neuropsychological Dysfunction and Neuroimaging Abnormalities In Neurologically Intact Adult Patients with Sickle Cell Disease

Blood (2010) 116 (21): 3221.

https://doi.org/10.1182/blood.V116.21.3221.3221

Published: 2010

Journal Articles

Developmental Outcomes of Offspring of Adults Treated with Hydroxyurea in the Multicenter Study of Hydroxyurea.

F. Daniel Armstrong, Ph.D., Martin H Steinberg, MD, Samir K. Ballas, MD, Kenneth I. Ataga, MD, Myron A Waclawiw, PhD, Abdullah Kutlar, MD, Paul S. Swerdlow, MD, William F. McCarthy, Ph., D., for the MSH Extension Investigators

Blood (2009) 114 (22): 1543.

https://doi.org/10.1182/blood.V114.22.1543.1543

Published: 2009

Journal Articles

Patterns of Analgesic Utilization in the Multicenter Study of Hydroxyurea (MSH).

Samir K. Ballas, MD, William F. McCarthy, Ph., D., Robert I Bauseman, PhD, Oswaldo L Castro, MD, Paul S. Swerdlow, MD, Wally Smith, Myron A Waclawiw, PhD, Bruce A Barton, PhD

Blood (2009) 114 (22): 2577.

https://doi.org/10.1182/blood.V114.22.2577.2577

Published: 2009

Journal Articles

Pomalidomide Modifies Sickle Cell Related Organ Damage in Transgenic Mice with Sickle Cell Anemia.

Steffen E. Meiler, MD, Marlene Wade, Laure Moutouh de Parseval, MD, Laura G Corral, Paul S. Swerdlow, MD, Ferdane Kutlar, MD, Abdullah Kutlar

Blood (2009) 114 (22): 904.

https://doi.org/10.1182/blood.V114.22.904.904

Published: 2009

Journal Articles

Tetrahydrobiopterin (6R-BH4): Novel Therapy for Endothelial Dysfunction in Sickle Cell Disease

Lewis Hsu, MD, PhD, Kenneth I Ataga, M.D., Victor R. Gordeuk, MD, Paul S. Swerdlow, MD, Abdullah Kutlar, MD, Wally Smith, MD, J. Martin Johnston, MD, Ian A Chen, MD, MPH, FACP, Anne Greist, MD, Frances Flug, MD, Susumu Inoue, MD, Olise M. Nwose, MBBS, MRCPath, Saba Sile, MD, Emil Kakkis, MD, PhD

Blood (2008) 112 (11): lba-5.

https://doi.org/10.1182/blood.V112.11.lba-5.lba-5

Published: 2008

Journal Articles

Alterations in Protein-DNA Interactions in the γ-Globin Gene Promoter in Response to Butyrate Therapy

Tohru Ikuta, Yuet Wai Kan, Paul S. Swerdlow, Douglas V. Faller, Susan P. Perrine

Blood (1998) 92 (8): 2924–2933.

https://doi.org/10.1182/blood.V92.8.2924

Published: 1998

Journal Articles

Globin Messenger RNA in Hemoglobin H Disease

Edward J. Benz, Jr., M.D., Paul S. Swerdlow, B.S., Bernard G. Forget, M.D.

Blood (1973) 42 (6): 825–833.

https://doi.org/10.1182/blood.V42.6.825.825

Published: 1973

NARROW

Skin Blood Flow Measured By LSCI Demonstrates Treatment Effect of Chronic Transfusion Protocol in Sickle Cell Disease

Pomalidomide In Sickle Cell Disease: Phase I Study Of a Novel Anti-Switching Agent

Hypogonadism in Men with Sickle Cell Disease (SCD): Benign Hematology Clinic, Detroit Medical Center, Detroit, MI

Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice

Developmental Outcomes of Offspring of Adults Treated with Hydroxyurea in the Multicenter Study of Hydroxyurea.

Patterns of Analgesic Utilization in the Multicenter Study of Hydroxyurea (MSH).

Pomalidomide Modifies Sickle Cell Related Organ Damage in Transgenic Mice with Sickle Cell Anemia.

Tetrahydrobiopterin (6R-BH4): Novel Therapy for Endothelial Dysfunction in Sickle Cell Disease

Alterations in Protein-DNA Interactions in the γ-Globin Gene Promoter in Response to Butyrate Therapy

Globin Messenger RNA in Hemoglobin H Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only